CONFIRMING XANAMEM'S EFFICACY

 

In a mouse model of Alzheimer’s disease, Xanamem was effective in improving cognitive function and in clearing amyloid plaques from the brain. The improved cognitive function was observed after only 4 weeks of treatment, and was maintained for at least 41 weeks. If Xanamem can be demonstrated to be as effective in humans, it has the potential to be one of the most meaningful global medical breakthroughs for treating Alzheimer’s disease in decades.